News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzon Pharmaceuticals, Inc. (ENZN) Stockholders Approve Sale of Specialty Pharmaceutical Business to Sigma-Tau Group


1/28/2010 9:05:14 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) ("Enzon") announced that at a special meeting held this morning, its stockholders approved the sale of Enzon's specialty pharmaceutical business to the sigma-tau Group ("sigma-tau").

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES